Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ETAPA: Early Targeted Paracetamol Treatment for Patent Ductus Arteriosus in Extremely Low Birth Weight Infants
2024-516846-20-00Phase 3Authorised
- Sponsor
- University College Dublin
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised trial in patent ductus arteriosus (PDA) comparing Paracetamol arm with Placebo arm (2 arms). Primary endpoint: Composite of severe intraventricular hemorrhage, necrotizing enterocolitis, and death. Planned start Sep 2021; status: authorised.
02
Drugs
acetaminophen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on 2024-516846-20-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516846-20-00.